BALAXI - Balaxi Pharmaceuticals

Balaxi Pharmaceuticals

BALAXI · Retail > Trading · MD: Ashish Maheshwari · Listing date: Nov. 30, 2015 · Hyderabad · http://www.balaxiventures.in/

Stock Price vs Company Growth

1.6%

2.0%

6.2%

25.3%

34.3%

52.0%

29.5%

10y

22.6%

all

23.5%

🤔 How to analyze this graph?

Last Traded Price

₹ 25 1.6%

15.2

29.9

Company Overview

Sales

276 Cr

Growth: -2.6%

Profit after Tax

9.44 Cr

Growth: -34.9%

Micro Cap

138 Cr

P/E: 14.6x

Industry P/E: 26.5x

Fundamentals

Sales (Cr)	₹ 276
Growth	-2.6%
EBITDA	7.6%
P/S	0.5x
Dividend	0.0%
P/E	14.6x
Book Value	₹ 31.7
PEG Ratio	-5.6x
ROE	5.4%
P/B	0.8x

Shareholding Pattern

Institutions

Elara India Opportunities Fund Limited

9.5 %

Marshal Global Capital Fund Ltd

9.5 %

Amol Anand Mantri

1.73 %

Iepf

0.75 %

Promoters

Balaxi Overseas Private Limited

70.0 %

Ashish Maheshwari

1.81 %

Minoshi Maheshwari

1.06 %

Others

Increase Decrease No change

Company Profile Detailed

The company is engaged in the business of international wholesale trading of Pharmaceuticals, Builders Hardware and FMCG productsHistory and Milestones2003-07Commenced Pharmaceutcal business by supplying white labeled products to customers in Africa.Sourcing was from WHO GMP certified plants based in India.2008-10Created frontend presence for its Pharmaceutical Business by setting up 1st wholesale depot in Angola in 2008.

Investors (20)

nexpact

hedge.eq...

iepf

Followers (1)

gmuralik